Chronic Lymphatic Leukemia (CLL) is the most common type of leukemia in adults in the West. It mainly affects elderly patients and its incidence is expected to increase due to the progressive increase in life expectancy in our society. Today is an incurable disease, with a development that can be indolent or more aggressive. Knowing […]
Patients with solid organ transplants, due to the transplant process itself, hospital admission and immunosuppression, among other factors, are frequently colonized or infected by antibiotic resistant bacteria. In a study published recently in the Scientific Reports journal [doi: 10.1038 / s41598-019-45060-y], IDIVAL researchers belonging to the group of Epidemiology and Pathogenic and Molecular Mechanisms of […]
Last May, the British journal “Nuclear Medicine Communications” published the work entitled “A 5-year longitudinal evaluation in patients with mild cognitive impairment by 11C-PIB PET / CT: a visual analysis” that gathers results of the longitudinal study that the Service of Nuclear Medicine of the University Hospital Marqués de Valdecilla (HUMV) and the Molecular Imaging […]
Researchers of the Marqués de Valdecilla University Hospital and the Valdecilla Sanitary Research Institute Foundation (IDIVAL) have discovered that a genetic variant in the PLCG2 gene protects against several forms of dementia. According to the results of the study, carried out in collaboration with researchers from the UMC University of Amsterdam, this genetic variation not […]
The research group “Cell Signalling and Therapeutic Targets in Cancer” of the Valdecilla Health Research Institute Foundation (IDIVAL) and the Marqués de Valdecilla University Hospital have genetically identified a new variant of the autistic spectrum in a pediatric patient by applying techniques of massive sequencing. Known as the ADNP syndrome, the identification of this variant […]
Dr. Marcos López Hoyos, Head of the Immunology Service of the Marqués de Valdecilla University Hospital (Santander, Cantabria) and principal investigator of the Transplant and Autoimmunity IDIVAL group, has been proclaimed incoming President of the SEI (Spanish Society of Immunology). The result of the elections was 100 votes in favor and 5 votes blank. The […]
Carried out in collaboration with CIC bioGUNE, this study promotes the development of a therapy that attenuates liver injury and slows the progression of these pathologies. A research project of the digestive pathology group of the HUMV and the IDIVAL that paves the way for the development of a therapy that attenuates liver injury and […]
During 2018 IDIVAL processed 9 patent applications, representing three times the number of applications with respect to the 2013 and previous annuities. Factors such as the promotion of the innovative culture, the certification of the institute by the UNE 166: 002, as well as the incorporation of new specific aids of innovation and technological development […]
The calcified aortic stenosis (AD) is the third most frequent cardiovascular disease in developed countries, after coronary heart disease and hypertension, with a prevalence of 0.4% in the general population and 1.7% in the population older than 65. It is characterized by progressive thickening and calcification of the valves of the aortic valve that, over […]
The Marquesa de Pelayo Library, depends organically of IDIVAL, has participated in the design and implementation of the National Catalog of Health Sciences (CNCS) led by the National Library of Health Sciences, recently presented at the Madrid office of ISCIII. The catalog reflects the printed and electronic funds of all libraries specialized in Health Sciences […]
